Mylan Laboratories Ltd.
|BSE: 524794||Sector: Health care|
|NSE: MATRIXLABS||ISIN Code: INE604D01023|
|BSE 05:30 | 01 Jan||Mylan Laboratories Ltd|
|NSE 05:30 | 01 Jan||Mylan Laboratories Ltd|
Mylan Laboratories Ltd. (MATRIXLABS) - Latest News & Headlines
2.34 pm | 29 Dec 2017 | Press Trust of India
Biocon said biosimilar trastuzumab will be manufactured by it and supplied to Libbs for commercialisation in Brazil